Skip to main content
PMC home page
Journal of the National Medical Association logoLink to Journal of the National Medical Association
. 2007 Mar;99(3):254–257.

Why blacks do not take part in HIV vaccine trials.

Demetrius L Moutsiakis 1, P Nancy Chin 1
PMCID: PMC2569631  PMID: 17393949

Abstract

BACKGROUND: AIDS is still a major cause of death. To combat this disease, researchers are developing a vaccine. Although blacks account for most new infections in the United States, they account for a low percent of experimental vaccine recipients. This study, conducted in a mid-sized U.S. city where vaccine trials are held, seeks to learn why. METHODS: We conducted 11 in-depth ethnographic interviews. Two groups were targeted: blacks who had not participated in HIV vaccine trials and blacks who had. RESULTS: Overall, three major causes of nonparticipation were identified: misinformation, fear/mistrust and stigma. Factors that favored participation included having close friends with HIV and being homosexual. CONCLUSIONS: HIV is considered by many blacks to be a gay, white disease. Steps to increase participation must include efforts to destigmatize the condition and disseminate accurate information. Efforts to address historical causes of mistrust through "education" alone are insufficient. Trust needs to be earned through long-term relationships with black communities.

Full text

PDF
254

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Corbie-Smith G. The continuing legacy of the Tuskegee Syphilis Study: considerations for clinical investigation. Am J Med Sci. 1999 Jan;317(1):5–8. doi: 10.1097/00000441-199901000-00002. [DOI] [PubMed] [Google Scholar]
  2. Corbie-Smith Giselle, Thomas Stephen B., St George Diane Marie M. Distrust, race, and research. Arch Intern Med. 2002 Nov 25;162(21):2458–2463. doi: 10.1001/archinte.162.21.2458. [DOI] [PubMed] [Google Scholar]
  3. Gamble V. N. A legacy of distrust: African Americans and medical research. Am J Prev Med. 1993 Nov-Dec;9(6 Suppl):35–38. [PubMed] [Google Scholar]
  4. Gamble V. N. Under the shadow of Tuskegee: African Americans and health care. Am J Public Health. 1997 Nov;87(11):1773–1778. doi: 10.2105/ajph.87.11.1773. [DOI] [PMC free article] [PubMed] [Google Scholar]
  5. Gifford Allen L., Cunningham William E., Heslin Kevin C., Andersen Ron M., Nakazono Terry, Lieu Dale K., Shapiro Martin F., Bozzette Samuel A., HIV Cost and Services Utilization Study Consortium Participation in research and access to experimental treatments by HIV-infected patients. N Engl J Med. 2002 May 2;346(18):1373–1382. doi: 10.1056/NEJMsa011565. [DOI] [PubMed] [Google Scholar]
  6. Gupta Kalpana, Hudgens Michael, Corey Lawrence, McElrath M. Juliana, Weinhold Kent, Montefiori David C., Gorse Geoffrey J., Frey Sharon E., Keefer Michael C., Evans Thomas G. Safety and immunogenicity of a high-titered canarypox vaccine in combination with rgp120 in a diverse population of HIV-1-uninfected adults: AIDS Vaccine Evaluation Group Protocol 022A. J Acquir Immune Defic Syndr. 2002 Mar 1;29(3):254–261. doi: 10.1097/00126334-200203010-00005. [DOI] [PubMed] [Google Scholar]
  7. Gupta Kalpana, Hudgens Michael, Corey Lawrence, McElrath M. Juliana, Weinhold Kent, Montefiori David C., Gorse Geoffrey J., Frey Sharon E., Keefer Michael C., Evans Thomas G. Safety and immunogenicity of a high-titered canarypox vaccine in combination with rgp120 in a diverse population of HIV-1-uninfected adults: AIDS Vaccine Evaluation Group Protocol 022A. J Acquir Immune Defic Syndr. 2002 Mar 1;29(3):254–261. doi: 10.1097/00126334-200203010-00005. [DOI] [PubMed] [Google Scholar]
  8. Gupta Kalpana, Hudgens Michael, Corey Lawrence, McElrath M. Juliana, Weinhold Kent, Montefiori David C., Gorse Geoffrey J., Frey Sharon E., Keefer Michael C., Evans Thomas G. Safety and immunogenicity of a high-titered canarypox vaccine in combination with rgp120 in a diverse population of HIV-1-uninfected adults: AIDS Vaccine Evaluation Group Protocol 022A. J Acquir Immune Defic Syndr. 2002 Mar 1;29(3):254–261. doi: 10.1097/00126334-200203010-00005. [DOI] [PubMed] [Google Scholar]
  9. Herek G. M., Capitanio J. P. Conspiracies, contagion, and compassion: trust and public reactions to AIDS. AIDS Educ Prev. 1994 Aug;6(4):365–375. [PubMed] [Google Scholar]
  10. Keefer M. C., Wolff M., Gorse G. J., Graham B. S., Corey L., Clements-Mann M. L., Verani-Ketter N., Erb S., Smith C. M., Belshe R. B. Safety profile of phase I and II preventive HIV type 1 envelope vaccination: experience of the NIAID AIDS Vaccine Evaluation Group. AIDS Res Hum Retroviruses. 1997 Sep 20;13(14):1163–1177. doi: 10.1089/aid.1997.13.1163. [DOI] [PubMed] [Google Scholar]
  11. Paul M. E. The immune system in vertical HIV infection: the immune response and disease progression. AIDS Res Hum Retroviruses. 1997 Jan 1;13(1):1–4. doi: 10.1089/aid.1997.13.1. [DOI] [PubMed] [Google Scholar]
  12. Paul M. E. The immune system in vertical HIV infection: the immune response and disease progression. AIDS Res Hum Retroviruses. 1997 Jan 1;13(1):1–4. doi: 10.1089/aid.1997.13.1. [DOI] [PubMed] [Google Scholar]
  13. Paul M. E. The immune system in vertical HIV infection: the immune response and disease progression. AIDS Res Hum Retroviruses. 1997 Jan 1;13(1):1–4. doi: 10.1089/aid.1997.13.1. [DOI] [PubMed] [Google Scholar]
  14. Paul M. E. The immune system in vertical HIV infection: the immune response and disease progression. AIDS Res Hum Retroviruses. 1997 Jan 1;13(1):1–4. doi: 10.1089/aid.1997.13.1. [DOI] [PubMed] [Google Scholar]
  15. Pinkerton S. D., Abramson P. R. A magic bullet against AIDS? Science. 1993 Oct 8;262(5131):162–163. doi: 10.1126/science.8211134. [DOI] [PubMed] [Google Scholar]
  16. Rudman D., Feller A. G., Nagraj H. S., Gergans G. A., Lalitha P. Y., Goldberg A. F., Schlenker R. A., Cohn L., Rudman I. W., Mattson D. E. Effects of human growth hormone in men over 60 years old. N Engl J Med. 1990 Jul 5;323(1):1–6. doi: 10.1056/NEJM199007053230101. [DOI] [PubMed] [Google Scholar]
  17. Santosham M., Rivin B., Wolff M., Reid R., Newcomer W., Letson G. W., Almeido-Hill J., Thompson C., Siber G. R. Prevention of Haemophilus influenzae type b infections in Apache and Navajo children. J Infect Dis. 1992 Jun;165 (Suppl 1):S144–S151. doi: 10.1093/infdis/165-supplement_1-s144. [DOI] [PubMed] [Google Scholar]
  18. Ward J., Brenneman G., Letson G. W., Heyward W. L. Limited efficacy of a Haemophilus influenzae type b conjugate vaccine in Alaska Native infants. The Alaska H. influenzae Vaccine Study Group. N Engl J Med. 1990 Nov 15;323(20):1393–1401. doi: 10.1056/NEJM199011153232006. [DOI] [PubMed] [Google Scholar]

Articles from Journal of the National Medical Association are provided here courtesy of National Medical Association

RESOURCES